文献速递先天性心脏病外科心外重症与机械循环支持

单心室辅助装置支持双向Glenn失败患者

Single Ventricular Assist Device Support for the Failing Bidirectional Glenn Patient.
PubMed 文献 · Ann Thorac Surg · 2020-03-06

该回顾性研究描述了2011年4月至2019年1月单中心对7例双向Glenn(BDG)患者行心室辅助装置(VAD)支持的经验,分析了手术策略、并发症和死亡原因,比较了不同策略下至心脏移植的生存情况。结果显示2例成功桥接至心脏移植,3例术后2周内死亡,2例30天后死于卒中。

要点

  • VAD支持BDG患者可采用搏动性或连续流泵、心房或心室插管、保留或拆除BDG。
  • 7例中2例成功桥接至心脏移植,生存者分别支持174天和72天。
  • 早期死亡3例(2例呼吸衰竭,1例感染),后期死亡2例(卒中)。

核心结论

  • BDG患者VAD支持的手术策略和术后管理仍在演变,成功支持可通过搏动或连续流泵、心房或心室插管、保留或拆除BDG实现。

研究设计与样本

  • 回顾性单中心研究,纳入2011年4月至2019年1月7例BDG患者,体重5.6至28.8 kg,年龄7个月至11岁,均行VAD植入。

主要发现

  • 3例植入Berlin Heart EXCOR,2例植入HeartWare HVAD,2例植入体外连续流装置。
  • 4例行心室流入道插管,3例行心房流入道插管。
  • VAD植入时BDG保留3例,拆除3例,新建1例。
  • 总VAD支持420天,2例存活至心脏移植:1例HeartWare心室插管+BDG保留(174天后),1例Berlin Heart心房插管+BDG拆除(72天后)。
  • 3例VAD植入后2周内死亡(2例呼吸衰竭,1例感染),2例30天后死于卒中。

临床怎么用

  • 手术策略应根据患者个体解剖、生理和病情确定,可考虑搏动或连续流泵、心房或心室插管、保留或拆除BDG。

局限性

  • 回顾性单中心小样本经验(7例),策略异质性大,结论需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Given poor outcomes, strategies to improve ventricular assist devices (VADs) for single-ventricle patients with bidirectional Glenn (BDG) palliation are needed. METHODS: This retrospective review describes an institutional experience with VAD support for patients with BDG from April 2011 to January 2019. Surgical strategies, complications, and causes of death are described. Survival to heart transplantation for various strategies are compared. RESULTS: A total of 7 patients with BDG (weights, 5.6 to 28.8 kg; ages, 7 months to 11 years) underwent VAD implantation. Three patients underwent implantation of Berlin Heart EXCOR devices (Berlin Heart, Inc, Spring, TX), 2 had HeartWare HVADs (Medtronic, Minneapolis, MN) implanted, and 2 patients underwent implantation of paracorporeal continuous flow devices. Four patients underwent ventricular inflow cannulation, and 3 underwent atrial inflow cannulation. At the time of VAD implantation, the BDG was left intact in 3 patients, taken down in 3 patients, and created de novo in 1 patient. Over a total of 420 VAD support days, 2 patients survived to heart transplantation, 1 patient with HeartWare ventricular cannulation and intact BDG (after 174 days) and another with Berlin Heart atrial cannulation and BDG take-down (after 72 days). There were 3 deaths within 2 weeks of VAD implantation (2 from respiratory failure, 1 from infection) and 2 deaths after 30 days as a result of strokes. CONCLUSIONS: The surgical strategy and postoperative management of VAD with BDG are still evolving. Successful support can be achieved with (1) both pulsatile and continuous flow pumps, (2) atrial or ventricular cannulation, and (3) with or without BDG take-down. Surgical strategy should be determined by individual patient anatomy, physiology, and condition.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Maeda K, Nasirov T, Yarlagadda V, et al. Single Ventricular Assist Device Support for the Failing Bidirectional Glenn Patient. Ann Thorac Surg. 2020. PMID: 32151575. doi:10.1016/j.athoracsur.2019.12.088

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。